This topic contains a solution. Click here to go to the answer

Author Question: The physician is treating a child with meningitis with a course of antibiotic therapy. The nurse ... (Read 60 times)

luvbio

  • Hero Member
  • *****
  • Posts: 623
The physician is treating a child with meningitis with a course of antibiotic therapy. The nurse assures the parents that the child will be out of isolation when:
 
  a. the course of antibiotics is complete.
  b. a negative CNS culture is obtained.
  c. the antibiotics have been initiated for 24 hours.
  d. the child has no symptoms of the disease.

Question 2

The patient who is allowed to take a tub bath should be told the maximum length of time to remain in the water is:
 
  a. 5 to 10 minutes.
  b. 10 to 20 minutes.
  c. 20 to 30 minutes.
  d. 30 to 40 minutes.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

iman

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

C
The child with bacterial meningitis is isolated until antibiotic therapy has been administered for at least 24 hours.

Answer to Question 2

B
A patient should not stay in the water for more than 20 minutes.




luvbio

  • Member
  • Posts: 623
Reply 2 on: Jul 11, 2018
:D TYSM


debra928

  • Member
  • Posts: 342
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

For a complete list of videos, visit our video library